As of 2023, the global gene therapy market was valued at approximately USD 9.0 billion. The increasing investment in research and development, coupled with favorable regulatory frameworks, has propelled the market's growth. The gene therapy market is expected to grow at a compound annual growth rate (CAGR) of around 21.4% from 2023 to 2031. By the end of 2031, the market could reach an estimated USD 42.46 billion, reflecting the increasing adoption of gene therapies for various genetic disorders and conditions.